Shantanu Kumar Singh is Executive Director and chief financial officer of {Taj Pharmaceuticals Company}. He was elected executive of the company’s board effective June 2014. SHANTANU KUMAR SINGH WAS ELECTED EXECUTIVE OF THE COMPANY’S BOARD EFFECTIVE JUNE 2014 . A PHARMA VETERAN FOR MORE THAN 10 YEARS, SINGH SERVED AS BANKER OF MORGAN STANLEY FROM 2011 TO 2012. PREVIOUSLY, HE WAS LEADING MARKETING OF TAJ PHARMA RUSSIA AND CIS, THE COMPANY’S LARGEST AFFILIATE, FROM 2009 TO 2012. HE SERVED AS SALES DIRECTOR AND GENERAL MANAGER OF TAJ ACTIVE PHARMACEUTICALS INGREDIENTS , OPERATING IN ONE OF THE INDIA’S FASTEST-GROWING EMERGING MARKETS, FROM 2012 TO 2014. AND HE WAS GENERAL MANAGER OF TAJ PHARMA MENA FROM 2009 TO 2010, AFTER ROLES AS DIRECTOR OF PHARMACEUTICAL MARKETING AND NATIONAL SALES DIRECTOR IN THAT COUNTRY. SHANTANU SINGH JOINED TAJ PHARMA IN 2008 AS A BUSINESS DEVELOPMENT ASSOCIATE AND HELD SEVERAL MA NAGEMENT ROLES IN INDIAN MARKETING AND SALES BEFORE MOVING TO TAJ PHARMA CIS DIVISION IN MOSCOW, RUSSIA.
Taj Pharma India delivers a unique contribution to better healthcare. Taj Pharma India aim to reduce suffering and improve health and quality of life of people all around the world. At Taj Pharmaceuticals, Taj Pharma India have pursued this mission with patience, dedication, imagination and skill, for over a century. Taj Pharma vision is to develop targeted medicines and diagnostic tools that combine to offer patients, physicians and payers better, safer, more cost-effective healthcare.
